HCA
HCA Healthcare, Inc
HCA Healthcare, Inc historical holders
total: 11
Appaloosa Management HCA Healthcare, Inc transactions over time
- Total transactions:
- 33
- New positions:
- 4
- Sold out:
- 4
- Added:
- 10
- Reduced:
- 15
- Held since:
- 2023 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2024 Q1
David Tepper has been an institutional investor in HCA Healthcare, Inc (HCA) since at least 2013 Q2. According to 2026 Q1 report, David Tepper doesn't hold any shares. In our earliest available record from 2013 Q2, Appaloosa Management held about 3.92M shares of HCA. David Tepper later completely sold out the position and reinvested in HCA again in 2023 Q4. Since at least 2013 Q2, Appaloosa Management has made 32 more transactions in this position.
When did David Tepper exit their HCA position?
David Tepper no longer holds HCA Healthcare, Inc (HCA). They sold off their entire position in 2024 Q1, closing out an investment that began in 2013 Q2.
Has David Tepper reinvested in HCA after selling?
Yes, David Tepper has shown renewed interest in HCA Healthcare, Inc (HCA). After completely selling their position, they reinitiated an investment in 2023 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $270.68
- Weighted AVG sell price:
- $270.68
HCA transactions history by Appaloosa Management
33 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$270.68
|
|
-100% (-117,198)
|
-0.56%
|
|
2023 Q4
|
0.56%
|
117,198
|
$270.68
|
$31,723,155
|
new
|
+0.56%
|
|
2023 Q2
|
0.00%
|
0
|
$263.68
|
|
-100% (-142,500)
|
-2.03%
|
|
2023 Q1
|
2.03%
|
142,500
|
$263.68
|
$37,574,400
|
-21.92% (-40,000)
|
-0.78%
|
|
2022 Q4
|
3.25%
|
182,500
|
$239.96
|
$43,792,700
|
+143.33% (+107,500)
|
+1.91%
|
|
2022 Q2
|
0.79%
|
75,000
|
$168.07
|
$12,605,000
|
new
|
+0.79%
|
|
2021 Q4
|
0.00%
|
0
|
$242.72
|
|
-100% (-387,000)
|
-2.24%
|
|
2021 Q3
|
2.24%
|
387,000
|
$242.72
|
$93,933,000
|
-4.44% (-18,000)
|
-0.09%
|
|
2021 Q2
|
1.73%
|
405,000
|
$206.74
|
$83,730,000
|
-57.37% (-545,000)
|
-1.62%
|
|
2021 Q1
|
2.57%
|
950,000
|
$188.34
|
$178,923,000
|
-5.00% (-50,000)
|
-0.14%
|
|
2020 Q4
|
2.46%
|
$164.46
|
+6.95% (+65,000)
|
|||
|
2020 Q3
|
2.06%
|
$124.68
|
-10.95% (-115,000)
|
|||
|
2020 Q2
|
1.77%
|
$97.06
|
+268.42% (+765,000)
|
|||
|
2020 Q1
|
0.78%
|
$89.85
|
new
|
|||
|
2018 Q2
|
0.00%
|
$97.00
|
-100% (-282,884)
|
|||
|
2018 Q1
|
0.28%
|
$97.00
|
-48.83% (-270,000)
|
|||
|
2017 Q4
|
0.46%
|
$87.84
|
+200.95% (+369,173)
|
|||
|
2017 Q3
|
0.21%
|
$79.59
|
+9.54% (+16,000)
|
|||
|
2017 Q2
|
0.22%
|
$87.20
|
-65.61% (-320,000)
|
|||
|
2017 Q1
|
0.76%
|
$88.99
|
-57.41% (-657,539)
|
|||
|
2016 Q4
|
1.57%
|
$74.02
|
-7.41% (-91,690)
|
|||
|
2016 Q3
|
2.42%
|
$75.63
|
+1.64% (+20,000)
|
|||
|
2016 Q2
|
2.46%
|
$77.01
|
-61.65% (-1,956,483)
|
|||
|
2016 Q1
|
4.96%
|
$78.05
|
-30.06% (-1,363,640)
|
|||
|
2015 Q4
|
6.97%
|
$67.63
|
+27.68% (+983,526)
|
|||
|
2015 Q3
|
9.75%
|
$77.36
|
-15.08% (-630,988)
|
|||
|
2015 Q2
|
9.40%
|
$90.72
|
-14.72% (-722,057)
|
|||
|
2015 Q1
|
8.75%
|
$75.23
|
-2.08% (-104,000)
|
|||
|
2014 Q4
|
9.08%
|
$73.39
|
-5.94% (-316,300)
|
|||
|
2014 Q1
|
3.73%
|
$52.50
|
+4.42% (+225,500)
|
|||
|
2013 Q4
|
3.05%
|
$47.71
|
+11.55% (+528,300)
|
|||
|
2013 Q3
|
3.14%
|
$42.75
|
+16.57% (+650,000)
|
|||
|
2013 Q2
|
2.05%
|
$36.06
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.